Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (177)	7/10/2000 9:46:44 AM
From: scaram(o)uche	Respond to of 2243

Nigel: Sounds pretty good to me. Hopefully, the guy won't lose it again, if and when biotech hits tough times. That possibility lies a long time off, IMO. (very, very big smile) Still, I will never forget the stance which spawned the original T/FIF thread. A bit arrogant, too, given that recent past and even RELATIVE performance of late. However, net-net, looks like a constructive attitude. I agree.... yet more liquidity. Assume that a disproportionate share for Europe?? Thanks, all, for taking such good care of the sector while I was gone. Rick

To: nigel bates who wrote (177)	7/10/2000 10:25:32 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

Today's BioCentury..... top ten IPOs for 2000 raised $1.6B, of which about 230M (14%) came from Europe.